STUDY ON CANNABIS BASED POLYHERBAL FORMULATION IN PCOD

SINGLE ARM OPEN LABEL INTERVENTIONAL STUDY TO EVALUATE THE EFFICACY OF A CANNABIS BASED POLYHERBAL FORMULATION IN PATIENTS WITH PCOD - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/109986

Enrollment

Registered

2026-05-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Female subjects who have been diagnosed with PCOD Subjects in the age group between18 and 35 years Both inclusive Subjects willing to give a written informed consent and agree to come for a regular follow up visit Subjects diagnosed with PCOD and having irregular menstruation Subjects willing to abide by and comply with the study protocol Subjects who have not participated in a similar investigation in the past three months Subjects who have completed HRT or other treatments 2 months before the start of the study or who do not plan to undergo these treatments during the study

Exclusion criteria

Exclusion criteria: Subjects who have undergone invasive treatments like surgery within 3 months before screening into the study Subjects suffering from thyroid and hyperprolactinemia Subjects having any other active disease that may interfere with the study Any history of underlying uncontrolled medical illness, including diabetes mellitus hypertension HIV hepatitis severe anemia serious disorder of the heart and respiratory apparatus or any other serious medical illness Subjects who are pregnant or lactating A known history or present condition of allergic response/hypersensitivity to any ingredients and pharmaceutical products Subjects who had been part of any other clinical study within 3 months before screening into the study

Design outcomes

Primary

Measure	Time frame
1. Pelvic USG - Ovarian volume and follicular morphology 2. Hormonal assay - FSH and LH levelsTimepoint: baseline and 3 months	—

Secondary

Measure	Time frame
To study the efficacy of Cannabis based formulation on the regularity of Menstruation & Comparison of pain reduction after treatment regimen for 3 months Timepoint: baseline 3 6 9 months	—

Countries

India

Contacts

Public ContactDr Meghashree B

Prasanna College of Ayurveda and Hospital Belthangady

drkavithapradeep@gmail.com9008979169

Outcome results